The possible involvement of HLA class III haplotype (RAGE, HSP70 and TNF genes) in Alzheimer's disease

Current Alzheimer Research

Volumn 12, Issue 10, 2015, Pages 997-1005

  Boiocchi, Chiara ^a   Maggioli, Elisa ^b   Monti, Maria Cristina ^b   Zorzetto, Michele ^b   Sinforiani, Elena ^a   Cereda, Cristina ^a   Ricevuti, Giovanni ^b   Cuccia, Mariaclara ^b  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alzheimer's disease; Haplotype; HLA class III; HS70 polymorphisms; Neurodegeneration; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HEAT SHOCK PROTEIN 70; HLA ANTIGEN; HLA ANTIGEN CLASS 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 6; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; ONSET AGE;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; ANTIGENS, NEOPLASM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84959478245     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205012666151027130635     Document Type: Article

References (66)

1. 1] Mooijaart SP, Sattar N, Trompet S, Polisecki E, de Craen AJ, Schaefer EJ, et al. C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study. PLoS One 6: e23890 (2011)
2. 2] Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol 61: 668-672 (2004)
3. 3] Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68: 1902-1908 (2007)
4. 4] Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27: 24-31 (2006)
5. 5] Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA 100: 13632-13637 (2006)
6. 6] Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66: 407-414 (2009)
7. 7] Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emoational and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445-452 (2001)
8. 8] Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet 358: 461-467 (2001)
9. 9] Prokop S, Miller KR, Heppner FL. Microglia actions in Alzheimer’s disease. Acta Neuropathol 126: 461-477 (2013)
10. Schuitemaker A, Kropholler MA, Boellaard R, van derFlier WM, Kloet RW, van der Doef TF, et al. Microglial activation in Alzheimer’s disease: an (R)-[11 C] PK11195 positron emission tomography study. Neurobiol Aging 34: 128-136 (2013)
11. Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, et al. Microglia, amyloid, and cognition in Alzheimer’s disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32: 412-419 (2008)
12. 12] Varnum MM, Ikezu T. The classification of microglial activation phenotypes on neurodegeneration and regenera-tion in Alzheimer’s disease brain. Arch Immunol Ther Exp (Warsz) 60: 251-266 (2012)
13. 13] Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10: S18-S25 (2004)
14. 14] Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2: 185-194 (2002)
15. 15] Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, et al. Guideline for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14: 105-111 (2009)
16. 16] Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human NK cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157: 4741-4745 (1996)
17. 17] Carlo-Stella N, Badulli C, De Silvestri A, Bazzichi L, Martinetti M, Lorusso L, et al. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 24: 179-182 (2006)
18. 18] Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-955 (2001)
19. 19] Falcone C, Geroldi D, Buzzi MP, Emanuele E, Yilmaz Y, Fontana JM, et al. The-374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch Med Res 39: 320-325 (2008)
20. 20] Boiocchi C, Bozzini S, Buzzi MP, Schirinzi S, Zorzetto M, Pelissero G, et al. Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated? Rejuvenation Res 14: 67-73 (2011)
21. 21] De Paoli F, Cuccia Belvedere M, Martinetti M, Abbal M. Human MHC class III genes, BF and C4 Polymorphism, complotypes and HLA class I and II associations in the Lombardy population (Italy). Gene Geogr 1: 121-129 (1987)
22. 22] Yu YC, Yang Z, Blanchong CA, Miller W. The human and mouse MHC class III region: a parade of 21 genes at the centromeric segment. Immunology 21: 320-328 (2000)
23. 23] Suzue K, Zhou X, Eisen HN, Young RA. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci USA 94: 3146-3151 (1997)
24. 24] Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6: 435-442 (2000)
25. 25] Park J, Liu AY. JNK phosphorylates the HSF1 transcriptional activation domain: role of JNK in the regulation of the heat shock response. J Cell Biochem 82: 326-338 (2001)
26. 26] Luo W, Sun W, Taldone T, Rodina A, Chiosis G. Heat shock protein 90 in neurodegenerative diseases. Mol Neurodegener 5: 24 (2010)
27. 27] Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, et al. Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci USA 21: 721-726 (2003)
28. 28] Evans CG, Wisen S, Gestwicki JE. Heat shock proteins 70 and 90 inhibit early stages of amyloid β-(1-42) aggregation in vitro. J Biol Chem 281: 33182-33191 (2006)
29. 29] Ansar S, Burlison JA, Hadden MK XM, Desino KE, Bean J, et al. A non-toxic Hsp90 inhibitor protects neurons from Aβ-induced toxicity. Bioorg Med Chem Lett 17: 1984-1990 (2007)
30. 30] Kumar P, Ambasta RK, Veereshwarayya V, Rosen KM, Kosik KS, Band H, et al. CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism. Hum Mol Genet 16: 848-864 (2007)
31. 31] Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). report of the quality standards subcommittee of the american academy of neurology. Neurology 56: 1143-1153 (2001)
32. 32] Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118: 5-36 (2009)
33. 33] Shepherd CE, Thiel E, McCann H, Harding AJ, Halliday GM. Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch Neurol 57: 817-822 (2000)
34. 34] Arnaud L, Robakis NK, Figueiredo-Pereira ME. It may take inflammation, phosphorylation and ubiquitination to ’tangle’ in Alzheimer’s disease. Neurodegener Dis 3: 313-319 (2006)
35. 35] Gorlovoy P, Larionov S, Pham TT, Neumann H. Accumulation of tau induced in neurites by microglial proinfl ammatory mediators. FASEB J 23: 2502-2513 (2009)
36. 36] Griffin WS. Inflammation and neurodegenerative diseases. Am J Clin Nutr 83: 470S-474S (2006)
37. 37] Caruso C, Franceschi C, Licastro F. Genetics of neurodegenerative disorders. N Engl J Med 349: 193-194 (2003)
38. 38] Licastro F, Chiappelli M. Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background. Mech Ageing Dev 124: 539-548 (2003)
39. 39] Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2: 8 (2005)
40. 40] Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, et al. Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 26: 455-464 (2005)
41. 41] De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, Grazia De Simoni M. Inflammatory markers in Alzheimer's disease and multi-infarct dementia. Mech Ageing Dev 122: 1985-1995 (2001)
42. 42] Favatier F, Bornman L, Hightower LE, Gunther E, Polla BS. Variation in hsp gene expression and Hsp polymorphism: do they contribute to differential disease susceptibility and stress tolerance? Cell Stress Chaperones 2:111-155 (1997)
43. 43] Li JX, Tang BP, Sun HP, Feng M, Cheng ZH, Niu WQ. Interacting contribution of the five polymorphisms in three genes of Hsp70 family to essential hypertension in Uygur ethnicity. Cell Stress Chaperones 14:355-362 (2009)
44. 44] Clarimon J, Bertranpetit J, Boada M, Tarraga L, Comas D. HSP70-2 (HSPA1B) is associated with noncognitive symptoms in lateonset Alzheimer's disease. J Geriatr Psychiatry Neurol 16: 146-150 (2003)
45. 45] Maggioli E, Boiocchi C, Zorzetto M, Sinforiani E, Cereda C, Ricevuti G, et al. The Human Leukocyte Antigen Class III haplotype approach: new insight in Alzheimer’s disease inflammation hypothesis. Curr Alzheimer Res 10(10): 1047-1056 (2013)
46. 46] Tabone T, Mather DE, Hayden MJ. Temperature switch PCR (TSP): Robust assay design for reliable amplification and genotyping of SNPs. BMC Genom 1: 580 (2009)
47. 47] Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81: 559-575 (2007)
48. 48] Goate AM, Cooper DN, Hall C, Leung TK, Solomon E, Lim L. Localization of a human heat-shock HSP 70 gene sequence to chromosome 6 and detection of two other loci by somatic-cell hybrid and restriction fragment length polymorphism analysis. Hum Genet 75: 123-128 (1987)
49. 49] Milner CM, Campbell RD. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32: 242-251 (1990)
50. 50] Westman P, Partanen J, Leirisalo-Repo M, Koskimies S. HSP70-Hom NcoI polymorphism and HLA-associations in the Finnish population and in patients with ankylosing spondylitis or reactive arthritis. Eur J Immunogenet 21: 81-90 (1994)
51. 51] Ishihara M, Ohno S, Ishida T, Mizuki N, Ando H, Naruse T, et al. Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis. Tissue Antigens 46: 59-62 (1995)
52. 52] Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 7: 137-152 (2011)
53. 53] Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2: a006346 (2012)
54. 54] Eikelenboom P, Veerhuis R, Familian A, Hoozemans JJ, van Gool WA, Rozemuller AJ. Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications. Neurodegener Dis 5: 190-193 (2008)
55. Sharp FR, Massa SM, Swanson RA. Heat-shock protein protection. Trends Neurosci 22: 97-99 (1999)
56. 56] Giffard RG, Xu L, Zhao H, Carrico W, Ouyang Y, Qiao Y, et al. Chaperones, protein aggregation, and brain protection from hypoxic/ ischemic injury. J Exp Biol 207: 3213-3220 (2004)
57. 57] Beere HM. The stress of dying: the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 117: 2641-2651 (2004)
58. 58] Yenari MA. Heat shock proteins and neuroprotection. Adv Exp Med Biol 513: 281-299 (2002)
59. 59] Nagao RT, Kimpel JA, Key JL. Molecular and cellular biology of the heat-shock response. Adv Genet 28: 235-274 (1990)
60. 60] Welch WJ. The role of heat-shock proteins as molecular chaperones. Curr Opin Cell Biol 3: 1033-1038 (1991)
61. 61] Kakimura J, Kitamura Y, Takata K, Umeki M, Suzuki S, Shibagaki K, et al. Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J 16: 601-603 (2002)
62. 62] Wu YR, Fung HC, Lee-Chen GJ, Hsu Y, Lin SJ, Lin YY, et al. Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease. Hum Genet 114: 236-241 (2004)
63. 63] Zhang X, Xu Z, Zhou L, Chen Y, He M, Cheng L, et al. Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones 15: 675-686 (2010)
64. 64] Schroeder S, Reck M, Hoeft A, Stuber F. Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis. Crit Care Med 27: 1265-1270 (1999)
65. 65] Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M. Association between-G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 6: 79-82 (2001)
66. Di Bona D, Candore G, Franceschi C, Licastro F, Colonna-Romano G, Camma C, et al. Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev 61: 60-68 (2009).